Reply to: Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse. Godet C, Cadranel J, Frat JP, Ragot S, et al. Eur Respir J 2022;60:2201678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Godet C, Cadranel J, Frat JP, Ragot S, et al. Reply to: Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse. Eur Respir J 2022;60:2201678.
PMID: 36137593